1345 Avenue of the Americas
44 articles with Accenture
Veeva helps life sciences enterprises manage customer databases, track drug development, and organize clinical trials.
Collaboration will leverage cloud and data-driven insights to accelerate drug development, increase operational agility, reduce technology costs and develop the workforce of the future
Accenture and Intel Support Neuromorphic Research Project to Develop Robotic Arm for Wheelchair-Bound Pediatric Patients
Companies collaborate with researchers from Open University of Israel to develop and test wheelchair-mounted robotic arm with patients at ALYN Hospital Pediatric Rehabilitation Center NEW YORK & SANTA CLARA, Calif. & RA'ANANA, Israel--( BUSINESS WIRE )-- Accenture (NYSE: ACN) and Intel are supporting a neuromorphic computing research project led by the Neuro-Biomorphic Engineering Lab (NBEL) at the Open University of Israel in collaboration w
Companies selected for innovative technology-driven solutions to improve how people access, manage and finance healthcare
UCB Implements Accenture’s technology platform, INTIENT™ Pharmacovigilance
Invicro LLC Joins Accenture’s INTIENT™ Network to Help Advance Innovation in Drug Discovery and Scientific Research
Invicro is a global provider of imaging biomarkers, core lab services, advanced analytics and software solutions for drug discovery and development.
The INRC has tripled in size over the past year and now has more than 75 organizations, spanning leading universities around the world, government labs, neuromorphic startup companies, and now several Fortune Global 500 members.
The Medical Alley Association and Accenture Collaborate to Lead the Healthcare Transformation Initiative
Accenture will conduct market analysis to discover and define the realities of the current healthcare system, provide insights into the synergies of various sectors of healthcare, and design and deliver the structure needed for HTI–MA to improve health outcomes and decrease overall costs within the healthcare system.
Accenture Announces Collaboration with Bayer to Streamline Drug Development Processes through INTIENT Clinical Platform
Accenture has announced a collaboration with Bayer to implement the Accenture INTIENT Clinical platform to help simplify and speed its drug development processes.
Whenever drug companies come under criticism for the cost of their drugs, one of the defenses touted is that only about one in 10 drugs make it to market. As a broad figure, that’s probably about right, although at least one report ranks it higher, while another provides a bit more nuance.
Accenture recently published a new report, “New Science: Biopharma’s New Growth Machine.” In it, the report attempts to evaluate the last 20 years of trends in biopharma and use that data to develop projections for the future of the industry.
PerkinElmer Joins Accenture’s Life Sciences Ecosystem to Help Drive Innovation in Drug Discovery and Scientific Research
Announcement at 2019 Bio-IT World Conference & Expo syncs with PerkinElmer’s strategy to get labs from big data overload to research insights faster and easier
Accenture to Acquire ESP to Help Life Sciences Clients Digitize and Transform Manufacturing Operations
Planned acquisition will expand Accenture’s Industry X.0 capabilities and continue Accenture’s investment in Ireland
Tamr Joins Accenture’s Life Sciences Ecosystem to Help Drive Innovation in Drug Discovery and Scientific Research
Tamr Inc. today announced it has joined Accenture’s open partner ecosystem, designed to help independent software vendors (ISVs) and life science companies team more effectively to accelerate drug discovery efforts and improve patient outcomes.
Ayasdi has been named the Accenture HealthTech Innovation Challenge Innovation Champion, competing with more than 1,100 companies for the title
Accenture Expands Platform for Drug Discovery and Innovation with Creation of Life Sciences Partner Ecosystem
Open partner ecosystem designed to help independent software vendors (ISVs) and life sciences companies team more effectively to accelerate drug discovery efforts and, ultimately, improve patient outcomes.
Accenture Introduces Ella and Ethan, AI Bots to Improve a Patient’s Health and Care Using the Accenture Intelligent Patient Platform
Accenture (NYSE: ACN) has enhanced the Accenture Intelligent Patient Platform with the addition of Ella and Ethan, two interactive virtual-assistant bots that use artificial intelligence (AI) to constantly learn and make intelligent recommendations for interactions between life sciences companies, patients, health care providers (HCPs) and caregivers.
Accenture and Merck Collaborate with Amazon Web Services to Launch a Research Platform to Drive Innovation in Drug Discovery and Scientific Research
Cloud-based informatics research platform designed to help organizations in the life sciences industry improve productivity, efficiency and innovation in the early stages of drug development.
Accenture Positioned as a Leader in an IDC MarketScape: Worldwide Life Sciences Research & Development Vendor Assessment on IT Outsourcing for Third Consecutive Time
For the third consecutive time, Accenture is positioned as a Leader in the IDC MarketScape vendor assessment covering IT outsourcing (ITO) across the life sciences research and development (R&D) industry.
Accenture Seeks Emerging Innovators and Disruptors for Third Annual Accenture HealthTech Innovation Challenge
Call for applications to foster next-generation technology and innovation in the healthcare industry